Coherus BioSciences (CHRS) - Webpage traffic

Sign up to add (CHRS) to your portfolio and access more historical data.

59,000 478.9%
Est. monthly webpage visitors.

Sign up to access historical data

Sign up

Similar companies

Company Webpage traffic
Amgen
Amgen
AMGN		 583,000 21.3%
Gilead Sciences
Gilead Sciences
GILD		 333,000 19.4%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 6,000 21.8%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 18,000 143.2%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 28,000 265.1%

Month over Month

Est. monthly webpage visitors.

Dec 2024 59,000
Nov 2024 10,000
Oct 2024 19,000
Sep 2024 9,000
Aug 2024 8,000

How many visits coherus.com?

Coherus BioSciences has an estimate of 59,000 visitors to coherus.com in December. This is up since November.

Analyzing Webpage traffic, how is Coherus BioSciences performing compared to its industry peers?

Coherus BioSciences underperforms its industry peers when it comes to Webpage traffic, ranking in the 1st percentile.

Why is it important to track website traffic for Coherus BioSciences?

By staying updated on webpage traffic for Coherus BioSciences, investors can gain valuable insights into the company's digital performance, customer engagement and acquisition, and overall effectiveness of its online presence. Higher traffic can indicate greater visibility and potential customer exposure and a lower or decreasing traffic can indicate challenges with retaining customers.

Sign up and get more insights on Coherus BioSciences and its Webpage performance.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact